SCHEMBL7702037

SCHEMBL7702037

CNc1oc(-c2ccc(Cl)cc2)nc1S(=O)(=O)c1ccccc1

nearest known ligand 0.77

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.77
KMT2A Q03164 1/20 0.77
UBE2N P61088 1/20 0.69
MAPT P10636 9/20 0.66
TDP1 Q9NUW8 1/20 0.66
ALDH1A1 P00352 6/20 0.63
LMNA P02545 1/20 0.63
KDM4E B2RXH2 2/20 0.61
SMN1; SMN2 Q16637 3/20 0.56
HPGD P15428 2/20 0.56
ALOX12 P18054 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
TP53 P04637 3/20 0.55
GAA P10253 1/20 0.53
TSHR P16473 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7701075 0.91 MEN1 (0.82) MEN1KMT2AUBE2NMAPTALDH1A1
SCHEMBL7694685 0.87 MEN1 (1.00) MEN1KMT2AUBE2NMAPTALDH1A1
SCHEMBL7700613 0.86 MAPT (0.62) MEN1KMT2AUBE2NMAPTTDP1
SCHEMBL7694832 0.83 MEN1 (0.71) MEN1KMT2AUBE2NMAPTTDP1
SCHEMBL7663409 0.81 ALDH1A1 (0.72) MEN1KMT2AUBE2NMAPTTDP1
SCHEMBL7539415 0.80 KMT2A (0.67) MEN1KMT2AUBE2NMAPTTDP1
SCHEMBL15308654 0.79 MAPT (0.62) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL10040175 0.78 MAPT (0.65) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL25009190 0.78 MAPT (0.77) MEN1KMT2AMAPTTDP1ALDH1A1
SCHEMBL7667933 0.78 ALDH1A1 (0.67) MEN1KMT2AUBE2NMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002100842-A1 SULFONYLOXAZOLAMINES AND THEIR USE AS 5-HT6 LIGANDS MERCK PATENT GMBH (DE) 2002-12-19 WO claimed
WO-2002100842-A1 SULFONYLOXAZOLAMINES AND THEIR USE AS 5-HT6 LIGANDS MERCK PATENT GMBH (DE) 2002-12-19 WO disclosed